Call for Abstracts
Abstract submissions for the 2013 Oak Ridge Conference are now closed. Please contact conference liaison David Sainato if you have any questions regarding a submission.
Be a part of this internationally recognized conference by submitting an abstract for the poster session. Last year, more than 60 abstracts were submitted. Investigators are encouraged to submit abstracts on all areas of new technology for the clinical laboratory. Suggested areas include, but are not limited to:
- Lab-on-a-chip technologies
- Mass Spectrometry methods for clinical diagnostics
- Multiplex arrays for pathogen detection
- Robust point-of-care technologies for low-resource settings
- Sequencing technologies for clinical diagnostics
- Technologies for quantitative pathway mapping in tissues and cells
- Technologies for infectious disease diagnostics
- Nanotechnology for diagnostics
- Novel detection technologies
- Molecular imaging technologies
- Microfluidic technologies
- Multiplex profiling technologies
- Cell-based technologies
- Novel point-of-care technologies
CONFIRMATION OF SUBMISSION
Responding author will receive an automated email confirmation with a submission ID number. PLEASE KEEP THIS CONFIRMATION. Correspondence regarding the submission should reference the submission ID number.
NOTIFICATION OF ACCEPTANCE
The corresponding author will be notified by email of the committee’s decision in late February.
The conference committee will select abstracts for brief oral presentations based on novelty, scientific merit, and fit with the program. Authors who do not wish to make an oral presentation may indicate so on the abstract submission form.
All authors are required to register for the conference and pay the appropriate fee.
In order to be accepted for the conference, please note the following:
1. The content of the abstract must be clear, concise, and grammatically correct.
2. Abstracts and posters may not contain any type of advertising or logos
3. The content of the abstract must not have been previously published in a copyrighted, peer-reviewed journal, such as Clinical Chemistry, by one or more of the submitting authors.
4. Relevant technical information cannot be withheld on the grounds that such information is proprietary. Statements such as "results will be discussed" are unacceptable.
A well written abstract should include:
1. The objective of the study.
2. Sufficient information to demonstrate relevance to clinical laboratory medicine.
3. Sufficient description of the methodology.
4. Validation with sufficient data or other objective evidence to support conclusions.
5. Technical studies should include sufficient analytical data and rigorous statistical analysis.
6. Statement of results and conclusions
Corresponding Author – You must create an AACC account or log into your existing account to submit an abstract. Enter the information requested. All correspondence concerning the abstract will be sent only to this author.
Abstract Title – Enter the abstract title as it appears in the Abstract Body. The title should be brief and clearly indicate the nature of the work.
The first letter of the first word in the title should be in uppercase. All other initial characters of words in the title should be in lower case unless the word is a proper noun. Use boldfaced type for the title. End the title with a period. Space once, then begin the author information.
Example of a correctly formatted title:
A rapid, sensitive multiplexed assay for detection of viral nucleic acids using the FlowMetrix system.
Abstract Body – Follow these instructions.
1. Prepare an electronic file of your abstract using Microsoft Word.
2. START THE TEXT WITH THE ABSTRACT TITLE AND AUTHORS. You must include the title at the beginning of the text. The title must match the title entered in the online abstract form.
3. For each author, list the last name and then initials. Separate author entries with a comma and a single space before the next entry.
4. List the institutions for the authors. The order of the institutions should correspond to the author order. Cross-reference authors with institutions using superscript numbers. Place the numbers at the end of author entries, but at the beginning of institution entries.
Example of a correctly formatted title and author listing
A rapid, sensitive multiplexed assay for detection of viral nucleic acids using the FlowMetrix system. Smith PL¹, Walker-Peach CR², Fulton RJ¹, DuBois DB². ¹Luminex Corporation, DeSoto, TX, and ²Cenetron Diagnostics, Austin, TX.
1. Use single spacing, Times New Roman, 12pt. font.
2. Do not indent paragraphs.
3. Skip lines between paragraphs.
4. Indicate TM, ©, and ® symbols only upon the first occurrence of a name requiring the designation.
5. Abstracts may include no more than one table, graph, or figure (black and white only).
6. Abstracts with tables, graphs, or figures should not exceed 300 words.
7. Abstracts without tables, graphs, or figures should not exceed 500 words.
8. Abstracts must fit on one, 8 ½” x 11” page when properly formatted.
Attach the abstract file – Click the “Browse” button to select the abstract file on your computer.
Attach the graphic file (if applicable) – Click the “Browse” button to select the graphic file on your computer.
For questions about the interpretation of these criteria and how they apply to your proposed abstract, please contact the conference chair.
Jason Y. Park, MD, PhD, FCAP
Assistant Professor, Department of Pathology
UT Southwestern Medical Center
Dallas, TX 75235
For technical questions about using the online abstract submission form, please contact the AACC Webmaster.
For general questions regarding status of an abstract or other routine information, please contact Courtney George.